ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

Quantitative Perspectives on Cross-Asset Risk Premia Optimized skewness reversion in cross-asset factors and combining trend-managed equity beta with pure equity momentum

Published: 2026-07-10Institution: JPMorganPages: 63Original language: 英语Evidence page: 1

Research evidence excerpt

Quantitative Perspectives on Cross-Asset Risk Premia Optimized skewness reversion in cross-asset factors and combining trend-managed equity beta with pure equity momentum

J P M O R G A N Global Markets Strategy

10 July 2026

Quantitative Perspectives on

Cross-Asset Risk Premia

Optimized skewness reversion in cross-asset factors

and combining trend-managed equity beta with pure

equity momentum

Cross Asset Systematic Strategy

Dobromir Tzotchev, PhD AC

(44-20) 7134-5331

dobromir.tzotchev@jpmorgan.com

J.P. Morgan Securities plc

Optimized Skewness Reversion in Cross-Asset Factors Ioannis Pantelidakis, DPhil

(44-20) 3493 3625

We construct the skewness-reversion in cross-asset factors approach as an alternative ioannis.pantelidakis@jpmorgan.com

to the asset-level skewness implementation. The skewness-reversion in factors J.P. Morgan Securities plc

strategy has a negligible correlation with the residual skewness counterpart. Mengjiao Wang

Optimized versions of skewness-reversion in factors have been put forward as well, (44-78) 9704-9696

one minimizing cost and another balancing skew-reversion expected return mengjiao.wang@jpmorgan.com

maximization with cost control, delivering Sharpe ratios close to 0.6. J.P. Morgan Securities plc

Sandra Djambazovska

Combining Trend-Managed Equity Beta with Pure Equity Momentum sandra.djambazovska@jpmorgan.com

Digressing from our usual approach of combining pure equity portfolios, we combine J.P. Morgan Securities plc

Pure Beta with Pure Momentum. We use a bottom-up variation of our trend signal to Thomas Salopek

dynamically adjust the risk level of the combined portfolio (Sharpe close to 0.7). We (1-212) 834-5476

also include a timed version of the Pure Beta portfolio. thomas.salopek@jpmorgan.com

J.P. Morgan Securities LLC

Performance review

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer